CAROLINA
MÉNDEZ BLANCO

PROFESOR AYUDANTE DOCTOR

Foto de CAROLINA

Foto de Complejo Asistencial Universitario de León

Complejo Asistencial Universitario de León

León, España

Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (5)

2024

Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

2023

Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)
Cancers

2019

Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells
Cancers, Vol. 11, Núm. 12

2018

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Experimental and Molecular Medicine, Vol. 50, Núm. 10

2017

Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy
Oncotarget, Vol. 8, Núm. 53, pp. 91402-91414